VB Spine has funded the next phase of scoliosis diagnostic research led by Alain Moreau, PhD, according to a June 3 news release.
Dr. Moreau’s research is looking into whether biomarkers present in patient blood could help predict spinal deformity progression. Initial studies in 2006 demonstrated proof of concept, and further per-reviewed research has validated the underlying science.
VB Spine’s funds will support a new phase that focuses on further clinical validation, FDA submission and commercialization of the predictive test.
“We are on the threshold of what could become the first truly predictive test to identify children at risk of developing severe scoliosis, opening the door to earlier interventions,” Dr. Moreau said in the release. “I am excited about this strategic alliance with VB Spine. It reflects a bold and forward-looking vision and long-standing commitment to bringing transformative innovations to patients.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
